Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.
Also called NCT03818581
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 108 participants
- Registry
-
NCT03818581
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03818581. Randomized; double masking; primary purpose treatment. Start 2019-03-15 (actual); primary completion 2021-11-03 (actual). Results posted on 2023-03-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Insomnia
- Condition
- Sleep Disorder
- Condition
- Inflammation
- Intervention (Drug)
- Suvorexant
- Intervention (Other)
- Placebo
- Lead sponsor
- Massachusetts General Hospital
Record details
- Record id
cardio:ct-nct03818581- Content hash
005e02c23b7604163c33dd4b36c8fafd7c1e2e74b535fd27aa60fa6aa0d51ad4